Clinical Trial Update: Consequences of Anti-interleukin 6 Immunotherapy Treatment for Rheumatoid Arthritis on Periodontium [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of anti-IL-6 immunotherapy for rheumatoid arthritis on the periodontium; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis
• Rheumatoid Arthritis

Snippet

Sponsor: Nantes University Hospital | Conditions: Rheumatoid Arthritis, Periodontitis | Phase 4 | Status: TERMINATED